SKLB-03220   Click here for help

GtoPdb Ligand ID: 12353

Synonyms: compound 12d [PMID: 36692394] | SKLB03220
Compound class: Synthetic organic
Comment: SKLB-03220 is reported as an orally bioavailable, covalent inhibitor of the histone methyltransferase, and oncology drug target, EZH2 [1]. Its chemical structure is based on that of the approved EZH2 inhibitor tazemetostat. SKLB-03220 abolishes epigenetic H3K27me3 marks.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 11
Topological polar surface area 103.53
Molecular weight 556.3
XLogP 6.25
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCN(c1cc(cc(c1C)C(=O)NCc1c(C)cc([nH]c1=O)C)c1cc(ccc1C)NC(=O)C=C)C1CCOCC1
Isomeric SMILES O=C(NCc1c(C)cc(C)[nH]c1=O)c1c(C)c(N(CC)C2CCOCC2)cc(c2cc(NC(=O)C=C)ccc2C)c1
InChI InChI=1S/C33H40N4O4/c1-7-31(38)36-25-10-9-20(3)27(18-25)24-16-28(32(39)34-19-29-21(4)15-22(5)35-33(29)40)23(6)30(17-24)37(8-2)26-11-13-41-14-12-26/h7,9-10,15-18,26H,1,8,11-14,19H2,2-6H3,(H,34,39)(H,35,40)(H,36,38)
InChI Key QKOGMESAENVJHH-UHFFFAOYSA-N
Bioactivity Comments
SKLB-03220 provides persisting EZH2 inhibition, that translates to in vitro and in vivo anticancer efficacy [1]. Inhibition of mutated EZH2 variants remains below 10 nM.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
enhancer of zeste 2 polycomb repressive complex 2 subunit Hs Inhibitor Inhibition 8.8 pIC50 - 1
pIC50 8.8 (IC50 1.72x10-9 M) [1]
Description: Inhibition of wild type EZH2 in vitro